Jiangsu's biopharmaceutical industry continues to develop rapidly and is opening up a "blue ocean"

 Biomedicine is not only an important engine for economic development, but also a major livelihood project
.
It is understood that in recent years, Jiangsu's biopharmaceutical industry has continued to develop rapidly, and the number of newly approved drugs for the market has been at the forefront for five consecutive years
.
At the same time, the stock of medical device product registrations has grown steadily, with a total of 11,764 Class II medical device registration certificates
.
Biomedicine has always been a “dazzling business card” in Jiangsu's industrial clusters.
In recent years, Jiangsu Province has taken biomedicine as an important foundation for improving Jiangsu's economic resilience
.
Data show that in 2020, the output value of Jiangsu's biomedical industry will account for about 1/6 of the country's total.
During the "Thirteenth Five-Year Plan" period, Jiangsu Province has been approved for 15 innovative drugs
.
Biomedicine is the "No.
1 Industry" of Suzhou City
.
According to data, in 2020, Suzhou's biopharmaceutical industry will complete sales revenue of over 200 billion yuan, of which the output value of the pharmaceutical industry is 175 billion yuan, an increase of more than 20%; the city has more than 50 billion yuan of biomedical industry funds, which will help the biomedical industry develop and grow.
Provides strong support
.
It is understood that in terms of promoting the development of the biopharmaceutical industry, Jiangsu Province has not only shown the sincerity of “real money”, the provincial special funds have supported the development of the province’s biomedicine industry with an annual support scale of 750 million yuan, and continued to encourage innovation; Policies have also continued to provide support
.
For example, in 2020, Jiangsu Province issued the "Jiangsu Province "Industrial Strong Chain" Three-year Action Plan (2021-2023)" (referred to as the "Action Plan"), which puts forward the goal of strengthening the biomedical industry chain to achieve excellence
.
This year, Jiangsu Province issued the "Several Policy Measures on Promoting the High-Quality Development of the Province's Biomedical Industry" (referred to as "Policy Measures"), proposing 30 measures to support and promote the development of the province's biomedical industry
.
Recently, the Jiangsu Provincial Market Supervision Bureau, the Provincial Food and Drug Administration, and the Provincial Intellectual Property Office have recently jointly issued the "Opinions on Deepening Reform and Innovation to Promote the High-quality Development of the Biopharmaceutical Industry" (the "Opinions"), which will fully implement market supervision, drug Responsibilities of supervision and intellectual property rights to promote the high-quality development of the biomedical industry
.
For example, the "Opinions" put forward 18 measures in five aspects: stimulating industrial innovation vitality, accelerating listing review and approval, promoting the quality improvement of the pharmaceutical industry, strengthening the construction of technical support capabilities, and improving the working mechanism of service development.
The bottleneck problem of development
.
The "Policy Measures" propose to accelerate the construction of a biomedical industry chain supply chain with stronger innovation, higher added value, safer and more reliable
.
By 2024, the basic capabilities of the province's biomedical industry and the modernization level of the industrial chain will continue to improve, the proportion of innovative drugs and high-end medical devices with independent intellectual property rights will increase significantly, and a number of key core technologies that restrict the high-quality development of the biomedical industry will be overcome.
Build a batch of world-class biomedical companies, gather a batch of top scientific and technological talents and teams, form a batch of biomedical industry clusters and specialized parks with core competitiveness, and build a nationally leading and globally influential biomedical industry cluster
.
In promoting the development of China's biomedical industry, Jiangsu shoulders an important mission
.
Regarding the future development of the biopharmaceutical industry, relevant people said that to enhance the competitiveness of the biopharmaceutical industry in Jiangsu Province, it is also necessary for all regions to work together to promote the flow of resources, to further solve the difficulties, pain points, and blockages of various links, and to accelerate the construction of stronger innovation and higher A value-added, safer and more reliable biomedical industry chain supply chain
.
The industry also stated that if all parts of Jiangsu make use of their own advantages and play "combined punches", in the future, Jiangsu Pharmaceuticals will have greater potential in leading the formulation of standards in the field of biomedicine
.
Now that the implementation of various new policies is imminent, Jiangsu's biomedical industry is opening up a "blue ocean"
.